A5000206994- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pelvic floor disorders treatments
- Urinary Bladder and Prostate Research
- Respiratory Support and Mechanisms
- Cholinesterase and Neurodegenerative Diseases
- Heart Failure Treatment and Management
- Alzheimer's disease research and treatments
- Human Resource and Talent Management
- Asthma and respiratory diseases
- Dementia and Cognitive Impairment Research
- Neuroinflammation and Neurodegeneration Mechanisms
- Esophageal Cancer Research and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Attention Deficit Hyperactivity Disorder
- Ethics in Clinical Research
- Cardiovascular and exercise physiology
- Urinary Tract Infections Management
- Medical Education and Admissions
- Healthcare cost, quality, practices
- Tryptophan and brain disorders
- Urinary and Genital Oncology Studies
- Bladder and Urothelial Cancer Treatments
University of Aberdeen
2019-2024
University of California, San Diego
2002
Parkwood Hospital
2001
Parkwood Institute
2001
Georgetown University Medical Center
2000
Mount Sinai Medical Center
2000
Georgetown University
2000
Laboratory and epidemiologic studies suggest that anti-inflammatory/immunosuppressive therapy may be useful in the treatment of AD. In preliminary studies, a regimen low to moderate dose prednisone was found suppress peripheral inflammatory markers without adverse effects subjects with AD.We conducted randomized, placebo-controlled multicenter trial determine whether slowed rate cognitive decline The active consisted an initial 20 mg daily for 4 weeks tapered maintenance 10 1 year, followed...
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Observational studies report that β-blocker use may be associated with reduced risk COPD exacerbations. However, recent trial reported metoprolol did not reduce exacerbations increased requiring hospital admission.
The purpose of this study was to identify risk factors for urinary retention (UR) in frail, elderly patients, determine its prevalence, and assess the validity use BladderScan BVI 2500+ ultrasound scanner measure postvoid residual urine volumes ≥ 150 ml. Probable UR defined as two consecutive scans with estimations estimates were confirmed by in- out-catheterization actual (PVR). Risk independent variables used regression analysis. Nineteen 167 people (11%) had UR. greatest among patients...
Background Around 7500 people are diagnosed with non-muscle-invasive bladder cancer in the UK annually. Recurrence following transurethral resection of tumour is common, and intensive monitoring schedule required after initial treatment has associated costs for patients NHS. In photodynamic diagnosis, before tumour, a photosensitiser that preferentially absorbed by cells instilled intravesically. Transurethral then conducted under blue light, causing to fluoresce. Photodynamic...
Multicentre randomised trials provide some of the key evidence underpinning healthcare practice around world. They are also hard work and generally expensive. Some this expense devoted to sites that fail recruit as many participants expected. Methods identify will target would be helpful. We asked trial managers at Centre for Healthcare Randomised Trials (CHaRT), University Aberdeen predict whether a site target. Predictions were made after initiation visit collected on form comprising...
Abstract Background Chronic obstructive pulmonary disease (COPD) is associated with significant morbidity, mortality and healthcare costs. Beta blockers are well-established drugs widely used to treat cardiovascular conditions. Observational studies consistently report that beta blocker use in people COPD a reduced risk of exacerbations. The bisoprolol study (BICS) investigates whether adding routine treatment has clinical cost-effective benefits. A sub-study will stratify participants for...
You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Incontinence Therapy I1 Apr 2014MP33-20 ANTICHOLINERGIC CYCLING AND TREATMENT OUTCOMES IN OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE Michael Chancellor, Riya Pulicharam, I-Ning Cheng, Karen Campbell, Catherine Corbell, Manher Joshi, and Denise Globe ChancellorMichael Chancellor More articles by this author , PulicharamRiya Pulicharam ChengI-Ning Cheng CampbellKaren Campbell CorbellCatherine Corbell...
Abstract Background : Chronic Obstructive Pulmonary Disease (COPD) is associated with significant morbidity, mortality and healthcare costs. Beta-blockers are well-established drugs widely used to treat cardiovascular conditions. Observational studies consistently report that beta-blocker use in people COPD a reduced risk of exacerbations. The bisoprolol study (BICS) investigates whether adding routine treatment has clinical cost-effective benefits. A sub-study will stratify participants for...